MODULIGHT OY EO 1 - Asset Resilience Ratio
MODULIGHT OY EO 1 (78W) has an Asset Resilience Ratio of 18.04% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 78W free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2023)
This chart shows how MODULIGHT OY EO 1's Asset Resilience Ratio has changed over time. See MODULIGHT OY EO 1 (78W) balance sheet quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down MODULIGHT OY EO 1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 78W market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €8.68 Million | 18.04% |
| Total Liquid Assets | €8.68 Million | 18.04% |
Asset Resilience Insights
- Good Liquidity Position: MODULIGHT OY EO 1 maintains a healthy 18.04% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
MODULIGHT OY EO 1 Industry Peers by Asset Resilience Ratio
Compare MODULIGHT OY EO 1's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for MODULIGHT OY EO 1 (2021–2023)
The table below shows the annual Asset Resilience Ratio data for MODULIGHT OY EO 1.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 38.65% | €24.72 Million ≈ $28.90 Million |
€63.96 Million ≈ $74.78 Million |
-15.39pp |
| 2022-12-31 | 54.04% | €42.32 Million ≈ $49.48 Million |
€78.31 Million ≈ $91.55 Million |
-17.34pp |
| 2021-12-31 | 71.38% | €62.47 Million ≈ $73.03 Million |
€87.52 Million ≈ $102.31 Million |
-- |
About MODULIGHT OY EO 1
Modulight Oyj designs, manufactures, and markets lasers products for medical and other diagnostic applications. The company offers laser products for clinical applications, biomedical illumination, and ophthalmology; plug and play laser systems; laser modules and components; and diode laser chips, bars, and wafers. The company was incorporated in 2000 and is based in Tampere, Finland.